GBA3
GBA3 (glucosylceramidase beta 3, also known as cytosolic beta-glucosidase, GLUC, KLrP and CBGL1) is a neutral cytosolic beta-glycosidase with broad substrate specificity. It hydrolyses glycosylceramides and a range of dietary glycosides, and may contribute to xenobiotic metabolism. Browse Assay Genie's current range of GBA3 research reagents below, or read on for the biology behind the target.
GBA3 is a neutral cytosolic beta-glycosidase with a broad substrate specificity, and its activity is highest at neutral pH. In vitro it shows glucosylceramidase activity and hydrolyses galactosylceramides, glucosylsphingosines and galactosylsphingosines. These activities could point to a role in glycosylceramide catabolism. However, the activity is relatively low, and its significance in vivo is not clear. The same applies to its activity on the sphingosine substrates.
The enzyme can also hydrolyse a wide variety of dietary glycosides in vitro, including phytoestrogens, flavonols, flavones, flavanones and cyanogens, so it may play a part in the metabolism of xenobiotics. In vitro it also has transxylosylase activity. It uses xylosylated ceramides as xylosyl donors and cholesterol as the acceptor. It may further contribute to the catabolism of cytosolic sialyl free N-glycans. The GBA3 protein is predominantly expressed in human liver, kidney, intestine and spleen.
The GBA3 gene belongs to the glycoside hydrolase family 1 (Klotho subfamily), which explains the alias KLrP. HGNC also places it among the glucosylceramidases, alongside GBA1. Earlier names for the gene were glucosidase, beta, acid 3 (cytosolic). GBA3 is a polymorphic pseudogene. The most common allele is functional and encodes the full-length protein. Some individuals carry a single nucleotide polymorphism that introduces a premature stop codon, so that allele does not produce a functional protein. Alternative splicing gives multiple transcript variants.
GBA3 hydrolyses glucosylceramides, galactosylceramides and related sphingosines in vitro, making it a candidate for studying glycosylceramide catabolism, though its in vivo relevance remains unclear.
The enzyme hydrolyses dietary glycosides such as flavonols, flavones and phytoestrogens in vitro, so it is studied in xenobiotic metabolism.
GBA3 could contribute to the breakdown of cytosolic sialyl free N-glycans, which makes it relevant to glycan turnover research.
A common stop-codon variant makes GBA3 a polymorphic pseudogene, offering a model for studying functional and non-functional alleles across individuals.
GBA3 is a neutral cytosolic beta-glycosidase. In vitro it hydrolyses glucosylceramides, galactosylceramides, glucosylsphingosines and a range of dietary glycosides, and it has transxylosylase activity. Its physiological roles, including glycosylceramide catabolism and xenobiotic metabolism, are possible but not firmly established in vivo.
GBA3 is the HGNC symbol for glucosylceramidase beta 3. Aliases and previous symbols include GLUC, KLrP and CBGL1, and UniProt names the protein cytosolic beta-glucosidase. Earlier gene names were glucosidase, beta, acid 3 (cytosolic). Alternative splicing produces multiple transcript variants.
No. GBA3 is a polymorphic pseudogene. The most common allele is functional and encodes the full-length protein, but some individuals carry a single nucleotide polymorphism that creates a premature stop codon, so no functional full-length protein is made from that allele.
Other glucosylceramidases and glycoside hydrolase family members involved in glycosphingolipid metabolism.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9H227; product specifications from Assay Genie datasheets.